Back
CytoSorbents Corp. Stock Predictions
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
28
CTSO
CytoSorbents Corp.
Last Price:
$0.74
Seasonality Move:
20.99%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiCytoSorbents Corp. Stock Forecast
-
Is CytoSorbents Corp. Stock Undervalued?The current CytoSorbents Corp. [CTSO] share price is $0.74. The Score for CTSO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
CTSO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will CytoSorbents Corp. Stock Go Up Next Year?
Data Unavailable
CytoSorbents Corp. Stock Rating
Data Unavailable
CytoSorbents Corp. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
cytosorbents.com
52-Week Data
52-Week High:
1.61
52-Week Low:
0.60
Prediction Charts
Market Cap:
46.4M
Price in USD:
0.74
Volume:
66K
Beta:
0.70
Technical Analysis
SMA50:
0.81
SMA100:
0.89
SMA200:
0.96
52-Wk Change:
-23.42%
Stock Predictions
-
Is CytoSorbents Corp. stock public?Yes, CytoSorbents Corp. is a publicly traded company.
-
What is the CytoSorbents Corp. stock quote today?The CytoSorbents Corp. stock price is 0.74 USD today.
-
How to buy CytoSorbents Corp. stock online?You can buy CytoSorbents Corp. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 0.68 | 0.66 | 0.70 | 0.60 |
| Nov-17 | 0.66 | 0.66 | 0.70 | 0.66 |
| Nov-18 | 0.70 | 0.62 | 0.70 | 0.61 |
| Nov-19 | 0.62 | 0.64 | 0.68 | 0.61 |
| Nov-20 | 0.65 | 0.62 | 0.65 | 0.60 |
| Nov-21 | 0.62 | 0.71 | 0.71 | 0.61 |
| Nov-24 | 0.71 | 0.83 | 0.85 | 0.71 |
| Nov-25 | 0.83 | 0.84 | 0.85 | 0.78 |
| Nov-26 | 0.84 | 0.79 | 0.84 | 0.79 |
| Nov-28 | 0.78 | 0.81 | 0.83 | 0.77 |
| Dec-1 | 0.80 | 0.75 | 0.83 | 0.75 |
| Dec-2 | 0.79 | 0.77 | 0.82 | 0.75 |
| Dec-3 | 0.78 | 0.73 | 0.80 | 0.71 |
| Dec-4 | 0.72 | 0.74 | 0.75 | 0.70 |
CytoSorbents Corp. Earnings
Data Unavailable
CytoSorbents Corp. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.16 per share.
* CytoSorbents Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.